Ana Aventín
- Hematology top 5%
- Acute Myeloid Leukemia Research 11
- Chronic Myeloid Leukemia Treatments 6
- Multiple Myeloma Research and Treatments 2
- Genetics top 10%
- Chronic Lymphocytic Leukemia Research 6
- Myeloproliferative Neoplasms: Diagnosis and Treatment 3
-
- Retinoids in leukemia and cellular processes 2
-
- Eosinophilic Disorders and Syndromes 2
-
- Acute Lymphoblastic Leukemia research 2
- Co-authors
- Roberta La StarzaCristina MecucciMaria Paola MartelliHerman Van den BergheIwona WłodarskaPeter MarynenTeresa Vallespı́C Mecucci
- Cited by
- HematologyGeneticsMolecular Biology
In The Last Decade
Ana Aventín
18 papers receiving 591 citations
Peers
Comparison fields: 5 of 45
- Hematology 339
- Genetics 148
- Molecular Biology 350
- Rheumatology 56
- Public Health, Environmental and Occupational Health 94
Countries citing papers authored by Ana Aventín
This map shows the geographic impact of Ana Aventín's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ana Aventín with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ana Aventín more than expected).
Fields of papers citing papers by Ana Aventín
This network shows the impact of papers produced by Ana Aventín. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ana Aventín. The network helps show where Ana Aventín may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ana Aventín, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 32 | |
| 2 | 2009 | 50 | |
| 3 | 2003 | 4 | |
| 4 | 2002 | 1 | |
| 5 | Recurrent rearrangement of the Ewing's sarcoma gene, EWSR1, or its homologue, TAF15, with the transcription factor CIZ/NMP4 in acute leukemia. | 2002 | 85 |
| 6 | 2002 | 153 | |
| 7 | 2001 | 13 | |
| 8 | 1999 | 16 | |
| 9 | 1999 | 8 | |
| 10 | 1998 | 50 | |
| 11 | 1998 | 44 | |
| 12 | 1996 | 9 | |
| 13 | 1995 | 90 | |
| 14 | FISH analysis of typical t(5;12) (q32;p12) and variant t(10;12)(q23;p12) translocation in four patients with chronic myeloid disorders | 1994 | 4 |
| 15 | 1991 | 17 | |
| 16 | 1989 | 7 | |
| 17 | 1988 | 20 | |
| 18 | 1988 | 7 |
About Ana Aventín
Ana Aventín is a scholar working on Hematology, Genetics, Rheumatology, Dermatology and Pathology and Forensic Medicine, having authored 18 papers that have together received 610 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (11 papers), Chronic Lymphocytic Leukemia Research (6 papers), Chronic Myeloid Leukemia Treatments (6 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers), Acute Lymphoblastic Leukemia research (2 papers), Retinoids in leukemia and cellular processes (2 papers), Multiple Myeloma Research and Treatments (2 papers) and Eosinophilic Disorders and Syndromes (2 papers). The work is most often cited by research in Hematology (339 citations), Genetics (148 citations), Molecular Biology (350 citations), Rheumatology (56 citations) and Public Health, Environmental and Occupational Health (94 citations). Ana Aventín has collaborated with scholars based in Spain, Italy and Belgium. Frequent co-authors include Roberta La Starza, Cristina Mecucci, Maria Paola Martelli, Herman Van den Berghe, Iwona Włodarska, Peter Marynen, Teresa Vallespı́, C Mecucci, Massimo Negrini and Angelo Veronese. Their work appears in journals such as Blood, British Journal of Haematology, Cytogenetic and Genome Research, American Journal of Hematology and Leukemia Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.